- Home
- DKS vs RPRX Comparison
DKS vs RPRX Comparison
Compare DKS & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DKS
- RPRX
- Stock Information
- Founded
- DKS 1948
- RPRX 1996
- Country
- DKS United States
- RPRX United States
- Employees
- DKS N/A
- RPRX N/A
- Industry
- DKS Other Specialty Stores
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- DKS Consumer Discretionary
- RPRX Health Care
- Exchange
- DKS Nasdaq
- RPRX Nasdaq
- Market Cap
- DKS 14.6B
- RPRX 13.9B
- IPO Year
- DKS N/A
- RPRX 2020
- Fundamental
- Price
- DKS $209.87
- RPRX $35.69
- Analyst Decision
- DKS Buy
- RPRX Strong Buy
- Analyst Count
- DKS 20
- RPRX 3
- Target Price
- DKS $228.95
- RPRX $47.33
- AVG Volume (30 Days)
- DKS 1.6M
- RPRX 4.6M
- Earning Date
- DKS 09-03-2025
- RPRX 08-07-2025
- Dividend Yield
- DKS 2.30%
- RPRX 2.46%
- EPS Growth
- DKS 16.10
- RPRX 37.60
- EPS
- DKS 14.00
- RPRX 2.45
- Revenue
- DKS $13,599,143,000.00
- RPRX $2,263,845,000.00
- Revenue This Year
- DKS $4.62
- RPRX $29.35
- Revenue Next Year
- DKS $4.04
- RPRX $7.58
- P/E Ratio
- DKS $15.04
- RPRX $14.61
- Revenue Growth
- DKS 3.33
- RPRX 1.13
- 52 Week Low
- DKS $166.37
- RPRX $24.05
- 52 Week High
- DKS $254.60
- RPRX $36.43
- Technical
- Relative Strength Index (RSI)
- DKS 69.40
- RPRX 56.87
- Support Level
- DKS $203.67
- RPRX $35.22
- Resistance Level
- DKS $208.59
- RPRX $36.43
- Average True Range (ATR)
- DKS 5.82
- RPRX 0.64
- MACD
- DKS 2.65
- RPRX -0.07
- Stochastic Oscillator
- DKS 98.32
- RPRX 59.07
About DKS Dick's Sporting Goods Inc
Dick's Sporting Goods retails athletic apparel, footwear, and equipment for sports. Dick's operates digital platforms, about 720 stores under its namesake brand (including outlet stores and House of Sport), and about 130 specialty stores under the Golf Galaxy and other nameplates. Dick's carries private-label merchandise and national brands such as Nike, The North Face, Under Armour, Callaway Golf, and TaylorMade. Based in the Pittsburgh area, Dick's was founded in 1948 by the father of current executive chair and controlling shareholder Edward Stack.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.